|
|
Article: Study: No proof of Vytorin link to cancer
- Article from:
- AP Worldstream
- Article date:
- September 2, 2008
- Author:
CopyrightCopyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. (Hide copyright information)
|
New research into a possible link between a cholesterol-reducing drug and cancer concluded there was no proof to establish a connection, but other doctors warned that it should be used more carefully.
In a paper published Tuesday by the New England Journal of Medicine, Terje Pedersen and colleagues found that cancer occurred more frequently in patients taking Vytorin, a combination of Merck's Zocor and Schering-Plough's Zetia, than in people on a placebo pill. But that study was too small to stand as proof of a real link.
In a larger analysis of data considering the possible link between Vytorin and cancer, also published in the New England Journal of Medicine, ...